Hypertension management in high risk type II diabetes with CKD: Insights from recent trials with a focus on albuminuria. A case based discussion  Matthew.

Slides:



Advertisements
Similar presentations
Lysaght, J Am Soc Nephrol, 2002 Number of patients worldwide treated with chronic dialysis from 1990 to ,000 1,490,000 2,500,000.
Advertisements

Dick de Zeeuw Department of Clinical Pharmacology University Medical Center Groningen The Netherlands Early detection, prediction and potential treatment.
Section 4: Managing progression of CKD. Glomerulosclerosis Reduction in number of functioning glomeruli Increased blood flow to remaining nephrons Intraglomerular.
Randomized, double-blind, multicenter, controlled trial.
Dick de Zeeuw Department of Clinical Pharmacology University Medical Center Groningen The Netherlands Albuminuria; a tool for measuring non-blood pressure.
Diabetes and the Kidney Richard Kingston Department of Renal Medicine Kent and Canterbury Hospital.
Section 4: Managing progression of CKD
A study on serum concentrations of oxidized low-density lipoprotein β2-glycoprotein I complex in patients with normal and dyslipidemic lipid profiles 
Robert C. Stanton, MD  American Journal of Kidney Diseases 
2013 ACC/AHA cholesterol treatment guidelines
904 Hypertension Analysis of Stress Reduction Using Mindfulness Meditation and Yoga: Results From a Randomized Controlled Trial  K. Blom, B. Baker, M.
The accordion effect Journal of Indian College of Cardiology
Coronary spasm Journal of Indian College of Cardiology
Tetsuro Tsujimoto, Hiroshi Kajio  International Journal of Cardiology 
Case of Filarial Pericardial Effusion (PE) presented as cardiac temponade which subsequently resolved with treatment with pericardiocentesis and diethylcarbamazine 
Bifurcation aortic stent graft placement in a patient with abdominal aortic aneurysm and single kidney with renal artery stenosis  G. Ramesh, M. Sandeep 
Valvular heart disease in pregnancy: A review
Frederik Persson, Peter Rossing  Kidney International Supplements 
American Journal of Kidney Diseases 
Assessment of γ-GT functions as novel risk factor in patients suffering from angina, myocardial infarction and congestive heart failure  Sanghamitra Chakraborty,
Assessment of γ-GT functions as novel risk factor in patients suffering from angina, myocardial infarction and congestive heart failure  Sanghamitra Chakraborty,
Management of hypertension in patients with chronic kidney disease
Approach to the true resistant hypertensive and treatment approaches
Approach to the true resistant hypertensive and treatment approaches
Hypotension induced coronary spasm: A vascular access complication
M. Sriharibabu, K. Komali, T. Sivakumar, Bhimasen Soren 
Alan Gradman  Journal of Indian College of Cardiology 
Cardiovascular Disease and CKD: Core Curriculum 2010
An echocardiographic evaluation of cardiac functions in patients with liver cirrhosis: A hospital based study  Prahlad Karki, Suchay Parikh, Sanjib K.
Do it simple: Rescue of a radial catheter stuck in axillary artery
Journal of Indian College of Cardiology
Fractional flow reserve for all coronary lesions with intermediate stenosis, a step towards optimal PCI – Single centre experience in India  Ashish Kumar,
Epidemiology of hypertension in India: Insights from PURE
Epidemiology of hypertension in India: Insights from PURE
Eric Peterson  Journal of Indian College of Cardiology 
M. Sriharibabu, K. Komali, T. Sivakumar, Bhimasen Soren 
Glycemic control for macrovascular disease in type II diabetes: Evidence and insights from recent trials  Sanjay Rajagopalan  Journal of Indian College.
Andrew Narva  American Journal of Kidney Diseases 
Need for better diabetes treatment for improved renal outcome
Journal of Indian College of Cardiology
Tetsuro Tsujimoto, Hiroshi Kajio  International Journal of Cardiology 
If triglycerides matter, why do they matter?
Daniel E. Weiner, MD, MS  American Journal of Kidney Diseases 
2013 ACC/AHA cholesterol treatment guidelines
Salt and Hypertension American Journal of Kidney Diseases
This Month in AJKD American Journal of Kidney Diseases
Albuminuria as a predictor of cardiovascular and renal outcomes in people with known atherosclerotic cardiovascular disease  Johannes F.E. Mann, Qi-Long.
Robert C. Stanton, MD  American Journal of Kidney Diseases 
Volume 74, Issue 3, Pages (August 2008)
D. Batlle, P. Ramadugu, M.J. Soler  Kidney International 
The epidemiology of chronic kidney disease
Study of Heart and Renal Protection (SHARP)
Volume 377, Issue 9771, Pages (March 2011)
Aggressive blood pressure reduction and renin–angiotensin system blockade in chronic kidney disease: time for re-evaluation?  Pantelis A. Sarafidis, Luis.
Baseline Characteristics, Blood Pressures, and Laboratory Values
Volume 85, Issue 3, Pages (March 2014)
Volume 87, Issue 1, Pages (January 2015)
Heated water-based exercise training reduces 24-hour ambulatory blood pressure levels in resistant hypertensive patients: A randomized controlled trial.
The kidney, a cardiovascular risk marker, and a new target for therapy
Clinical renoprotection trials involving angiotensin II-receptor antagonists and angiotensin-converting-enzyme inhibitors  Barry M. Brenner, Joann Zagrobelny 
This Month in AJKD American Journal of Kidney Diseases
KDOQI US Commentary on the 2017 ACC/AHA Hypertension Guideline
Effect of proteinuria and glomerular filtration rate on cardiovascular risk in essential hypertension  Julian Segura, Carlos Campo, Luis M. Ruilope  Kidney.
Michael R. Lattanzio, Matthew R. Weir  Kidney International 
Is it the low-protein diet or simply the salt restriction?
This Month in AJKD American Journal of Kidney Diseases
Cardiovascular risk in chronic kidney disease
Volume 87, Issue 3, Pages (March 2015)
Lipoprotein abnormalities in diabetic nephropathy
Clinical Practice Guidelines for Peritoneal Dialysis Adequacy
Presentation transcript:

Hypertension management in high risk type II diabetes with CKD: Insights from recent trials with a focus on albuminuria. A case based discussion  Matthew Weir  Journal of Indian College of Cardiology  Volume 5, Pages S104-S109 (March 2015) DOI: 10.1016/j.jicc.2015.03.021 Copyright © 2015 Indian College of Cardiology Terms and Conditions

Fig. 1 Annual transition rates through stages of albuminuria in patients with type 2 diabetes. Source: Adler A, et al. Kidney Int. 2003;63:225–32 Journal of Indian College of Cardiology 2015 5, S104-S109DOI: (10.1016/j.jicc.2015.03.021) Copyright © 2015 Indian College of Cardiology Terms and Conditions

Fig. 2 RENAAL: proteinuria reduction at month 6 determines the cardiovascular outcome. Source: De Zeeuw et al. Circulation. 2004;110:921–927 Journal of Indian College of Cardiology 2015 5, S104-S109DOI: (10.1016/j.jicc.2015.03.021) Copyright © 2015 Indian College of Cardiology Terms and Conditions

Fig. 3 Yearly average clinic systolic blood pressure (mmHg). Journal of Indian College of Cardiology 2015 5, S104-S109DOI: (10.1016/j.jicc.2015.03.021) Copyright © 2015 Indian College of Cardiology Terms and Conditions

Fig. 4 Occurrence of microalbuminuria during the 48-month follow-up period in the two study groups. Source: Haller H, et al. N Engl J Med 2011;364:907–17 Journal of Indian College of Cardiology 2015 5, S104-S109DOI: (10.1016/j.jicc.2015.03.021) Copyright © 2015 Indian College of Cardiology Terms and Conditions

Fig. 5 IRMA 2 primary endpoint development of overt proteinuria. Journal of Indian College of Cardiology 2015 5, S104-S109DOI: (10.1016/j.jicc.2015.03.021) Copyright © 2015 Indian College of Cardiology Terms and Conditions